Novo Nordisk partners with OpenAI to AI-power drug development

Bookmark (0)
Please login to bookmark Close

The Danish pharmaceutical company has a strategic plan to use AI across its business. OpenAI is helping it to achieve this objective

​The Danish pharmaceutical company has a strategic plan to use AI across its business. OpenAI is helping it to achieve this objective Read More